JUL 22, 2015 1:59 PM PDT

Inhibiting Mast Cell Degranulation: A New Therapy For Macular Degeneration

WRITTEN BY: Kara Marker
The American Journal of Pathology recently published a study that yields promising results in the search for better treatment options for people suffering from chronic eye problems like macular degeneration. Essentially, problems result from these disorders because fluid accumulates in and around the retina when mast cells release substances during degranulation. Scientists in the recently published study found a compound that could inhibit the release of substances, making it a potential new therapy for chronic eye problems.


Mast cells are immature leukocytes (white blood cells) circulating in the blood before they move on to tissues to differentiate into more specific cells. "Within seconds of stimulation, mast cells can undergo degranulation," releasing factors like histamine (PLoS Pathogens). Histamine is a compound that, in response to an infection of foreign particles, opens up pores in small blood vessels to allow leukocytes and proteins access to fight the foreign invaders. Histamine and other products of degranulation can lead to a buildup of fluid in the retina.

The theory in this new study is that "repeated exposure to stimuli" induces degranulation of mast cells, and over time, the large amount of degranulation products emitted from mast cells contributes to chronic eye problems. To test this theory, scientists compared three experimental groups of test rats' eyes: 1) rats with a right eye injection of a degranulation-activating compound, 2) the non-injected left eye of the same rat, and 3) rat eyes injected with only saline solution.

The experiment resulted in visible mast cell degranulation after 15 minutes post-injection with the intended compound, while "no clinical abnormalities were seen in the untreated left eye." They used optical coherence tomography (OCT), a new technique that uses light to provide images of tissue structure, similarly to how ultrasound uses sound to produce pictures (Neoplasia Press). The OCT results showed "large and multiple retinal serous detachments" in the rat eyes treated with the mast cell degranulation-activating compound.

In the next part of the experiment, the scientists discovered that another compound, disodium cromoglycate, lowered the rate of serous retinal detachment from 80% to 16% when it was administered before the degranulation-activating compound. Disodium cromoglycate was found in 1969 to "inhibit discharge of the mediators of mast cells" (Nature). At the time it was used to experimentally reduce the allergic response of asthmatics, but in the current study it is also effective at indirectly treating eye problems associated with retinal detachment.

In the future, scientists hope to use disodium cromoglycate as part of the treatment for macular degeneration and other chronic eye problems caused by retinal detachment. Check out the video below to understand better the characteristics of macular degeneration:



Source: Elsevier
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JAN 15, 2020
Clinical & Molecular DX
JAN 15, 2020
Laser microchip picks up cancer markers in urine
A future where patients no longer need to endure expensive, painful and complicated cancer tests could soon become a reality. Researchers have developed a...
JAN 13, 2020
Cardiology
JAN 13, 2020
Drinking Tea Linked to Better Heart Health
Researchers from the Chinese Academy of Medical Sciences in Beijing have found that drinking black or green tea three or more times per week helps improve ...
JAN 13, 2020
Microbiology
JAN 13, 2020
Using Food to 'Sculpt' the Gut Microbiome
Scientists are learning more about how the antimicrobial effect of some foods and how it alters the microbial community in the gut....
JAN 15, 2020
Drug Discovery & Development
JAN 15, 2020
FDA Approves Drugs Faster than Ever- But is That Good?
The Food and Drug Administration (FDA) is approving new drugs for patients on less and less evidence thanks to special programs that streamline their appro...
JAN 16, 2020
Health & Medicine
JAN 16, 2020
Babies in Africa Receive World's First Malaria Vaccine
Would you accept a vaccine that was only 40% effective? For those at risk of malaria, the answer is likely a resounding, "yes!" According to the...
FEB 03, 2020
Neuroscience
FEB 03, 2020
Genetic Characterization of Bipolar Disorders, Major Depressive Disorder
Mood disorders, like Bipolar, Major Depressive Disorder, and Schizophrenia, among others, are difficult to define clinically.  Unlike disorders that a...
Loading Comments...